1. Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement‐dependent anti‐tumor activity of trastuzumab and pertuzumab. Issue 3 (20th February 2013) Authors: Mamidi, Srinivas; Cinci, Marc; Hasmann, Max; Fehring, Volker; Kirschfink, Michael Journal: Molecular oncology Issue: Volume 7:Issue 3(2013) Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗